Max Bayer - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Max Bayer's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Max Bayer
Verified
Reporter, Endpoints News
New York
Beats
Social justice healthcare leadership ethical business
Content
By Max Bayer Verified| Endpoints News Verified A CDC advisory panel voted to recommend RSV vaccines for at-risk adults aged 50 to 59, a sought-after expansion by vaccine makers who are trying …Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
By Max Bayer Verified| Endpoints News Verified The 340B drug discount program may move under the purview of CMS, according to a leaked HHS restructuring document reviewed by Endpoints News. …Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
By Max Bayer Verified| Endpoints News Verified The 340B drug discount program may move under the purview of CMS, according to a leaked HHS restructuring document reviewed by Endpoints News. …Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Company Info
Endpoints News
Endpoints News is an independent news organization dedicated to the biopharmaceutical industry. Founded in 2016 by Arsalan Arif and John Carroll, it has established itself as a trusted source of information, boasting over 163,000 subscribers, including executives and scientific leaders from top pharmaceutical companies and biotech startups worldwide. The organization provides daily news reports, analysis, and events tailored for biopharma professionals. Its offerings include daily newsletters like the Early Edition, investigative reporting on drug development and regulatory updates, and in-person and virtual conferences such as the Endpoints Summit. Endpoints News emphasizes independent journalism and operates on a subscription model, providing premium content to subscribers while maintaining ad-free reporting. With a focus on both scientific and business aspects of the industry, it serves decision-makers across the global pharmaceutical landscape.
Lawrence, Kansas, United States
+1 785-813-1733
Founded: 2014